YAP, TAZ, and Yorkie: a conserved family of signal-responsive transcriptional coregulators in animal development and human diseaseThis paper is one of a selection of papers published in this Special Issue, entitled CSBMCB’s 51st Annual Meeting – Epigenetics and Chromatin Dynamics, and has undergone the Journal’s usual peer review process.
The DOI matches its Crossref record; 114 of the 114 references it cites were found in a registry or an index.
Abstract
How extracellular cues are transduced to the nucleus is a fundamental issue in biology. The paralogous WW-domain proteins YAP (Yes-associated protein) and TAZ (transcriptional coactivator with PDZ-binding motif; also known as WWTR1, for WW-domain containing transcription regulator 1) constitute a pair of transducers linking cytoplasmic signaling events to transcriptional regulation in the nucleus. A cascade composed of mammalian Ste20-like (MST) and large tumor suppressor (LATS) kinases directs multisite phosphorylation, promotes 14-3-3 binding, and hinders nuclear import of YAP and TAZ, thereby inhibiting their transcriptional coactivator and growth-promoting activities. A similar cascade regulates the trafficking and function of Yorkie, the fly orthologue of YAP. Mammalian YAP and TAZ are expressed in various tissues and serve as coregulators for transcriptional enhancer factors (TEFs; also referred to as TEADs, for TEA-domain proteins), runt-domain transcription factors (Runxs), peroxisome proliferator-activated receptor γ (PPARγ), T-box transcription factor 5 (Tbx5), and several others. YAP and TAZ play distinct roles during mouse development. Both, and their upstream regulators, are intimately linked to tumorigenesis and other pathogenic processes. Here, we review studies on this family of signal-responsive transcriptional coregulators and emphasize how relative sequence conservation predicates their function and regulation, to provide a conceptual framework for organizing available information and seeking new knowledge about these signal transducers.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Several studies have shown that Yap and Taz co-regulate not only Teads but also several other transcription factors, including Smads (143).”
From The Hippo signal transduction network for exercise physiologists (2016) · cites this paper as [143]
Citations
Cites
Zhao, B., Wei, X., Li, W., Udan, R. S., Yang, Q., Kim, J., Xie, J., Ikenoue, T., Yu, J., Li, L., et al. (2007) · Genes & Development · doi:10.1101/gad.1602907 · Cited by 3,092
TEAD mediates YAP-dependent gene induction and growth control
Zhao, B., Ye, X., Yu, J., Li, L., Li, W., Li, S., Yu, J., Lin, J. D., Wang, C.-Y., Chinnaiyan, A. M., et al. (2008) · Genes & Development · doi:10.1101/gad.1664408 · Cited by 2,498
Elucidation of a universal size-control mechanism in Drosophila and mammals
Dong, J., Feldmann, G., Huang, J., Wu, S., Zhang, N., Comerford, S. A., Gayyed, M. F., Anders, R. A., Maitra, A., & Pan, D. (2007) · Cell · doi:10.1016/j.cell.2007.07.019 · Cited by 2,370
Huang, J., Wu, S., Barrera, J., Matthews, K., & Pan, D. (2005) · Cell · doi:10.1016/j.cell.2005.06.007 · Cited by 1,863
YAP1 increases organ size and expands undifferentiated progenitor cells
Camargo, F. D., Gokhale, S., Johnnidis, J. B., Fu, D., Bell, G. W., Jaenisch, R., & Brummelkamp, T. R. (2007) · Current Biology · doi:10.1016/j.cub.2007.10.039 · Cited by 1,252
The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men
Yang, X.-J., & Seto, E. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2346 · Cited by 1,230
Self-citationKimura, S., Hara, Y., Pineau, T., Fernandez-Salguero, P., Fox, C. H., Ward, J. M., & Gonzalez, F. J. (1996) · Genes & Development · doi:10.1101/gad.10.1.60 · Cited by 1,222
The regulation of protein function by multisite phosphorylation – a 25 year update
Cohen, P. (2000) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)01712-6 · Cited by 1,136
Wu, S., Huang, J., Dong, J., & Pan, D. (2003) · Cell · doi:10.1016/s0092-8674(03)00549-x · Cited by 1,098
Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach
Zender, L., Spector, M. S., Xue, W., Flemming, P., Cordon-Cardo, C., Silke, J., Fan, S.-T., Luk, J. M., Wigler, M., Hannon, G. J., et al. (2006) · Cell · doi:10.1016/j.cell.2006.05.030 · Cited by 1,065
Research works printed but not linked: 6
- Afzelius B.A., 1979, Int. Rev. Exp. Pathol., 19, 1
- Irwin M.S., 2001, Cell Growth Differ., 12, 337
- 10.1002/(sici)1520-6408(1998)22:1<43::aid-dvg5>3.0.co;2-7 · DOI · Paper page
- Lam-Himlin D.M., 2006, Int. J. Gastrointest. Cancer, 37, 103
- Packham E.A., 2003, Hum Mol Genet., 12, R37–R44
- Sudol M., 1994, Oncogene, 9, 2145
Cited by
Hippo signaling: growth control and beyond
Halder, G., & Johnson, R. L. (2011) · Development · doi:10.1242/dev.045500 · Cited by 1,060
“When active, Hpo in complex with Sav phosphorylates Wts and its co-factor Mats, thereby activating Wts kinase activity (Wei et al., 2007; Wu et al., 2003); the pathway is now considered to be in an activated state (Fig.”
BackgroundKRAS and YAP1 Converge to Regulate EMT and Tumor Survival
Shao, D. D., Xue, W., Krall, E. B., Bhutkar, A., Piccioni, F., Wang, X., Schinzel, A. C., Sood, S., Rosenbluh, J., Kim, J. W., et al. (2014) · Cell · doi:10.1016/j.cell.2014.06.004 · Cited by 744
“YAP1 is a transcriptional co-activator that participates in several context-dependent transcriptional programs that regulate organ size and promote cell proliferation (Wang et al., 2009).”
BackgroundThe Hippo signaling pathway in stem cell biology and cancer
Mo, J., Park, H. W., & Guan, K. (2014) · EMBO reports · doi:10.15252/embr.201438638 · Cited by 674
“Besides the TEAD family transcription factors, YAP/TAZ also interacts with other transcription factors including Smad, Runx1/2, p73, ErbB4, Pax3, and T-box transcription factor 5 (TBX5) to mediate the transcription of a diverse array of genes, although the biological functions of these other transcription factors in m…”
YAP regulates cell mechanics by controlling focal adhesion assembly
Nardone, G., Oliver-De La Cruz, J., Vrbsky, J., Martini, C., Pribyl, J., Skládal, P., Pešl, M., Caluori, G., Pagliari, S., Martino, F., et al. (2017) · Nature Communications · doi:10.1038/ncomms15321 · Cited by 664
The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain
Lamar, J. M., Stern, P., Liu, H., Schindler, J. W., Jiang, Z.-G., & Hynes, R. O. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1212021109 · Cited by 654
“In addition, the WW domains, SH3-binding motif, and PDZ-binding motif (PDZbm) of YAP also can mediate interaction with several additional proteins (41).”
BackgroundSignaling Cross Talk between TGF-β/Smad and Other Signaling Pathways
Luo, K. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022137 · Cited by 639
The DREAM complex: master coordinator of cell cycle-dependent gene expression
Sadasivam, S., & DeCaprio, J. A. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3556 · Cited by 524
Su, M., Xiao, Y., Ma, J., Tang, Y., Tian, B., Zhang, Y., Li, X., Wu, Z., Yang, D., Zhou, Y., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1002-6 · Cited by 457
“Liu and colleagues [93] identified circRNA-000425 as a novel inhibitory target of Yes-associated protein 1 (YAP1), an transcriptional coactivator factor that acts as an oncogene associated with cancer malignancy in several cancer types [94, 95].”
BackgroundLai, D., Ho, K. C., Hao, Y., & Yang, X. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2711 · Cited by 416
Self-citationIdentification of a Disease-Defining Gene Fusion in Epithelioid Hemangioendothelioma
Tanas, M. R., Sboner, A., Oliveira, A. M., Erickson-Johnson, M. R., Hespelt, J., Hanwright, P. J., Flanagan, J., Luo, Y., Fenwick, K., Natrajan, R., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002409 · Cited by 401
Neto-Silva, R. M., de Beco, S., & Johnston, L. A. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.09.009 · Cited by 287
Hippo signaling in Drosophila: Recent advances and insights
Staley, B. K., & Irvine, K. D. (2012) · Developmental Dynamics · doi:10.1002/dvdy.22723 · Cited by 249
“The mammalian homologs of Yki (YAP and TAZ) had been reported to interact with several different DNA-binding proteins (reviewed in Bertini et al., 2009; Wang et al., 2009), but initially it was not clear which, if any, of them might be linked to Hippo signaling.”
BackgroundYAP Controls Endothelial Activation and Vascular Inflammation Through TRAF6
Lv, Y., Kim, K., Sheng, Y., Cho, J., Qian, Z., Zhao, Y.-Y., Hu, G., Pan, D., Malik, A. B., & Hu, G. (2018) · Circulation Research · doi:10.1161/circresaha.118.313143 · Cited by 239
TEADs Mediate Nuclear Retention of TAZ to Promote Oncogenic Transformation
Chan, S. W., Lim, C. J., Loo, L. S., Chong, Y. F., Huang, C., & Hong, W. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m901568200 · Cited by 239
TGF-β Synergizes with Defects in the Hippo Pathway to Stimulate Human Malignant Mesothelioma Growth
Fujii, M., Toyoda, T., Nakanishi, H., Yatabe, Y., Sato, A., Matsudaira, Y., Ito, H., Murakami, H., Kondo, Y., Kondo, E., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20111653 · Cited by 224
Oka, T., Remue, E., Meerschaert, K., Vanloo, B., Boucherie, C., Gfeller, D., Bader, G. D., Sidhu, S. S., Vandekerckhove, J., Gettemans, J., et al. (2010) · Biochemical Journal · doi:10.1042/bj20100870 · Cited by 216
Chen, J., Zhang, K., Zhi, Y., Wu, Y., Chen, B., Bai, J., & Wang, X. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.478 · Cited by 203
LATS tumor suppressor: A new governor of cellular homeostasis
Visser, S., & Yang, X. (2010) · Cell Cycle · doi:10.4161/cc.9.19.13386 · Cited by 202
Self-citationBao, Y., Nakagawa, K., Yang, Z., Ikeda, M., Withanage, K., Ishigami-Yuasa, M., Okuno, Y., Hata, S., Nishina, H., & Hata, Y. (2011) · Journal of Biochemistry · doi:10.1093/jb/mvr063 · Cited by 172
NPHP4, a cilia-associated protein, negatively regulates the Hippo pathway
Habbig, S., Bartram, M. P., Müller, R. U., Schwarz, R., Andriopoulos, N., Chen, S., Sägmüller, J. G., Hoehne, M., Burst, V., Liebau, M. C., et al. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201009069 · Cited by 162
“transcription, which is mediated predominantly by transcription factors of the TEA domain (TEAD) family (Wang et al., 2009).”
BackgroundYorkie: the final destination of Hippo signaling
Oh, H., & Irvine, K. D. (2010) · Trends in Cell Biology · doi:10.1016/j.tcb.2010.04.005 · Cited by 164
The role of LPA and YAP signaling in long-term migration of human ovarian cancer cells
Cai, H., & Xu, Y. (2013) · Cell Communication and Signaling · doi:10.1186/1478-811x-11-31 · Cited by 161
TAZ is a novel oncogene in non-small cell lung cancer
Zhou, Z., Hao, Y., Liu, N., Raptis, L., Tsao, M.-S., & Yang, X. (2011) · Oncogene · doi:10.1038/onc.2010.606 · Cited by 162
“TAZ, also called WW-domain containing transcription regulator 1 (WWTR1), is a WW-domain-containing transcriptional coactivator that activates many transcriptional factors, which have important roles in the development of various tissue in mammals (Wang et al., 2009).”
BackgroundSelf-citationPark, Y., Sohn, B. H., Johnson, R. L., Kang, M., Kim, S. B., Shim, J., Mangala, L. S., Kim, J. H., Yoo, J. E., Rodriguez‐Aguayo, C., et al. (2016) · Hepatology · doi:10.1002/hep.28223 · Cited by 152
“Of note, while expression of SLC38A1 was strongly affected by both YAP1 and TAZ, expression of SLC7A5 was significantly affected only by YAP1, supporting the notion that YAP1 and TAZ share similar functional roles but with slightly different specificities.(25) To validate the regulation of SLC38A1 and SLC7A5 by YAP1 a…”
BackgroundZhi, X., Zhao, D., Zhou, Z., Liu, R., & Chen, C. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.02.025 · Cited by 149
Yap is a novel regulator of C2C12 myogenesis
Watt, K. I., Judson, R., Medlow, P., Reid, K., Kurth, T. B., Burniston, J. G., Ratkevicius, A., Bari, C. D., & Wackerhage, H. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.02.034 · Cited by 144
miR-375 Is Activated by ASH1 and Inhibits YAP1 in a Lineage-Dependent Manner in Lung Cancer
Nishikawa, E., Osada, H., Okazaki, Y., Arima, C., Tomida, S., Tatematsu, Y., Taguchi, A., Shimada, Y., Yanagisawa, K., Yatabe, Y., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1020 · Cited by 138
Mitotic Exit and Separation of Mother and Daughter Cells
Weiss, E. L. (2012) · Genetics · doi:10.1534/genetics.112.145516 · Cited by 130
“This sequence closely matches sites phosphorylated by metazoan LATS/warts family protein kinases in the yorkie/ YAP/TAZ transcriptional co-activators (Zhao et al. 2007; Zhang et al. 2008; Wang et al. 2009), indicating that this consensus motif preference is conserved in Ndr/LATS family kinases.”
BackgroundMammalian Hippo pathway: from development to cancer and beyond
Bao, Y., Hata, Y., Ikeda, M., & Withanage, K. (2011) · Journal of Biochemistry · doi:10.1093/jb/mvr021 · Cited by 126
Abali, G. K., Alptekin, A., Lewis, M. S., Garraway, I. P., & Cinar, B. (2015) · Nature Communications · doi:10.1038/ncomms9126 · Cited by 128
Ameloblastoma: A Review of Recent Molecular Pathogenetic Discoveries
Brown, N. A., & Betz, B. L. (2015) · Biomarkers in Cancer · doi:10.4137/bic.s29329 · Cited by 149
Raghunathan, V. K., Morgan, J. T., Dreier, B., Reilly, C. M., Thomasy, S. M., Wood, J. A., Ly, I., Tuyen, B. C., Hughbanks, M., Murphy, C. J., et al. (2013) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.12-11007 · Cited by 116
Cytoplasmic ASPP1 inhibits apoptosis through the control of YAP
Vigneron, A. M., Ludwig, R. L., & Vousden, K. H. (2010) · Genes & Development · doi:10.1101/gad.1954310 · Cited by 114
Podocyte-Specific Deletion of Yes-Associated Protein Causes FSGS and Progressive Renal Failure
Schwartzman, M., Reginensi, A., Wong, J., Basgen, J. M., Meliambro, K. A., Nicholas, S. B., D’Agati, V. D., McNeill, H., & Campbell, K. N. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014090916 · Cited by 118
Coordinating developmental signaling: novel roles for the Hippo pathway
Varelas, X., & Wrana, J. L. (2011) · Trends in Cell Biology · doi:10.1016/j.tcb.2011.10.002 · Cited by 121
Inhibition of ERK1/2 down-regulates the Hippo/YAP signaling pathway in human NSCLC cells
You, B., Yang, Y., Xu, Z., Dai, Y., Liu, S., Mao, J., Tetsu, O., Li, H., Jablons, D. M., & You, L. (2015) · Oncotarget · doi:10.18632/oncotarget.2974 · Cited by 112
“In the Hippo pathway, YAP is negatively regulated by a core cassette consisted of LATS1, LATS2, MST1, and MST2 kinases [17, 23, 46].”
Proapoptotic Kinase MST2 Coordinates Signaling Crosstalk between RASSF1A, Raf-1, and Akt
Romano, D., Matallanas, D., Weitsman, G. E., Preisinger, C., Ng, T., & Kölch, W. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3147 · Cited by 117
WW domain-mediated interaction with Wbp2 is important for the oncogenic property of TAZ
Chan, S. W., Lim, C. J., Huang, C., Chong, Y. F., Gunaratne, H. J., Hogue, K. A., Blackstock, W. P., Harvey, K. F., & Hong, W. (2011) · Oncogene · doi:10.1038/onc.2010.438 · Cited by 102
“As many proteins other than 143-3 and TEAD proteins interact with YAP and/or TAZ (Wang et al., 2009), this seeming controversy likely reflects the fact that WW domains mediate a complex network of interactions with proteins that inhibit or promote Yorkie/YAP activity in cell and contextspecific manners.”
BackgroundPrognostic Significance of TAZ Expression in Resected Non-Small Cell Lung Cancer
Xie, M., Zhang, L., He, C.-S., Hou, J.-H., Lin, S.-X., Hu, Z.-H., Xu, F., & Zhao, H.-Y. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318248240b · Cited by 99
“Given that YAP and TAZ have independent and overlapping functions, it is possible that both YAP and TAZ may be involved in lung tumorigenesis in vivo.(15) In our study, NSCLC patients with TAZ positive expression demonstrated a significant survival benefit from adjuvant chemotherapy, whereas those with TAZ negative ex…”
BackgroundZhao, D., Zhi, X., Zhou, Z., & Chen, C. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr242 · Cited by 98
Zhao, Y., Khanal, P., Savage, P. B., She, Y., Cyr, T. D., & Yang, X. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2712 · Cited by 102
“YAP (Yes-associated protein) and TAZ (transcriptional coactivator with PDZ-binding motif) are paralogs of WW domain-containing transcriptional coactivators, which share 60% similarity and activate many transcriptional factors important for the development of various tissues in mammals (7, 8).”
BackgroundSelf-citationThe Hippo signal transduction network in skeletal and cardiac muscle
Wackerhage, H., Del Re, D. P., Judson, R. N., Sudol, M., & Sadoshima, J. (2014) · Science Signaling · doi:10.1126/scisignal.2005096 · Cited by 92
Hippo Signaling in Cancer: Lessons From Drosophila Models
Snigdha, K., Gangwani, K. S., Lapalikar, G. V., Singh, A., & Kango-Singh, M. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00085 · Cited by 79
Role of extracellular matrix and YAP/TAZ in cell fate determination
Hao, J., Zhang, Y., Wang, Y., Ye, R., Qiu, J., Zhao, Z., & Li, J. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.11.006 · Cited by 95
TEAD4 establishes the energy homeostasis essential for blastocoel formation
Kaneko, K. J., & Depamphilis, M. (2013) · Development · doi:10.1242/dev.093799 · Cited by 92
“Hippo signaling pathway The Hippo signaling pathway affects transcription by regulating subcellular localization of YAP1, a co-activator capable of interacting with at least 15 transcription factors, including TEAD4 (Wang et al., 2009).”
BackgroundPP1A-Mediated Dephosphorylation Positively Regulates YAP2 Activity
Wang, P., Bai, Y., Song, B., Wang, Y., Liu, D., Lai, Y., Bi, X., & Yuan, Z. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024288 · Cited by 92
“TAZ, a mammalian YAP2 homologue [31], has been shown to be dephosphorylated by PP1A (catalytic subunit of PP1).”
BackgroundYoshikawa, K., Noguchi, K., Nakano, Y., Yamamura, M., Takaoka, K., Hashimoto-Tamaoki, T., & Kishimoto, H. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.2948 · Cited by 84
Yes-associated Protein (YAP) Promotes Cell Survival by Inhibiting Proapoptotic Dendrin Signaling
Campbell, K. N., Wong, J., Gupta, R., Asanuma, K., Sudol, M., He, C., & Mundel, P. H. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.c113.457390 · Cited by 78
“Podocytes have a limited capacity to regenerate when they are injured, and loss of podocytes is a hallmark in the progression of proteinuric kidney disease (7, 15).”
BackgroundInfluentialSki regulates Hippo and TAZ signaling to suppress breast cancer progression
Rashidian, J., Le Scolan, E., Ji, X., Zhu, Q., Mulvihill, M. M., Nomura, D., & Luo, K. (2015) · Science Signaling · doi:10.1126/scisignal.2005735 · Cited by 71
Da, C.-L., Xin, Y., Zhao, J., & Luo, X.-D. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.4055 · Cited by 77
“The pathway consists of a tumor suppressor kinase cascade which negatively regulates growth and results in inactivation of a transcriptional coactivator, Yorkie (Yki) [ 8 ]”
BackgroundDubois, F., Vandermoere, F., Gernez, A., Murphy, J., Toth, R., Chen, S., Geraghty, K. M., Morrice, N. A., & MacKintosh, C. (2009) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m800544-mcp200 · Cited by 71
Jansson, L., & Larsson, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032013 · Cited by 69
“In the nucleus, Yap1 functions as a transcriptional coactivator, initiating transcription in complex with various transcription factors, such as p73, EGR-1, Runx 1/2 and particularly the TEA domain (TEAD) family [10,11].”
Huntoon, C. J., Nye, M. D., Geng, L., Peterson, K. L., Flatten, K. S., Haluska, P., Kaufmann, S. H., & Karnitz, L. M. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1345 · Cited by 77
“Phosphorylation of these transcription factors creates binding sites for 14-3-3 proteins, which localize and anchor YAP/TAZ in the cytoplasm, and directs YAP for proteolytic degradation.”
BackgroundMolecular mechanism of size control in development and human diseases
Yang, X., & Xu, T. (2011) · Cell Research · doi:10.1038/cr.2011.63 · Cited by 72
Self-citationLai, D., & Yang, X. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.05.002 · Cited by 71
Self-citationBai, N., Zhang, C., Liang, N., Zhang, Z., Chang, A., Yin, J., Li, Z., Li, N., Tan, X., Luo, N., et al. (2013) · Cancer Biology & Therapy · doi:10.4161/cbt.24345 · Cited by 63
VGLL4 is a transcriptional cofactor acting as a novel tumor suppressor via interacting with TEADs.
Deng, X., & Fang, L. (2018) · Europe PMC (PubMed Central) · Cited by 83
Two-signal requirement for growth-promoting function of Yap in hepatocytes
Su, T., Bondar, T., Zhou, X., Zhang, C., He, H., & Medzhitov, R. (2015) · eLife · doi:10.7554/elife.02948 · Cited by 64
“, 2007; Barry and Camargo, 2013) and is commonly observed in human cancers (Fernandez et al., 2009; Wang et al., 2009).”
BackgroundTargeting YAP in malignant pleural mesothelioma
Zhang, W., Dai, Y., Hsu, P., Wang, H., Cheng, L., Yang, Y., Wang, Y., Xu, Z., Liu, S., Chan, G., et al. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13182 · Cited by 64
“These findings suggest that YAP, as the major mediator of the Hippo pathway [31, 32], is involved in the elevation of transcriptional activity, and in turn controls mesothelioma cell proliferation, invasion and stem cell renewal abilities.”
BackgroundLabel-free quantitative proteomic analysis of the YAP/TAZ interactome
Kohli, P., Bartram, M. P., Habbig, S., Pahmeyer, C., Lamkemeyer, T., Benzing, T., Schermer, B., & Rinschen, M. M. (2014) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00339.2013 · Cited by 61
Osteoblast-Targeted Overexpression of TAZ Increases Bone Mass In Vivo
Yang, J., Cho, S. W., An, J. H., Jung, J. Y., Kim, S. W., Kim, S. Y., Kim, J. E., & Shin, C. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056585 · Cited by 65
yap is required for the development of brain, eyes, and neural crest in zebrafish
Qiu, J., Liu, D., Gong, Y., Wang, Y., Sun, S., Gui, Y., & Song, H. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.04.070 · Cited by 62
Jeong, G. O., Shin, S. H., Seo, E. J., Kwon, Y. W., Heo, S. C., Kim, K., Yoon, M., Suh, D., & Kim, J. H. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000354434 · Cited by 66
Yang, Z., Nakagawa, K., Sarkar, A., Maruyama, J., Iwasa, H., Bao, Y., Ishigami-Yuasa, M., Ito, S., Kagechika, H., Hata, S., et al. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.01346-13 · Cited by 57
“YAP1 is regulated by the Hippo pathway, junction proteins, and the actin cytoskeleton in a manner similar to that of TAZ regulation (3, 12, 13).”
BackgroundStructure of a 14-3-3σ–YAP phosphopeptide complex at 1.15 Å resolution
Schumacher, B., Skwarczynska, M., Rose, R., & Ottmann, C. (2010) · Acta Crystallographica Section F Structural Biology and Crystallization Communications · doi:10.1107/s1744309110025479 · Cited by 62
“The Yes-associated protein (YAP) is a WW-domain protein and belongs to a functional family of proteins that also includes TAZ (transcriptional coactivator with PDZ-binding motif; Wang et al., 2009) proteins.”
BackgroundIkmi, A., Gaertner, B., Seidel, C., Srivastava, M., Zeitlinger, J., & Gibson, M. C. (2014) · Molecular Biology and Evolution · doi:10.1093/molbev/msu071 · Cited by 55
“At the molecular level, Yap contains multiple functional domains, including TEAD-binding (TBD), WW, coiled-coil, and PDZ-binding motifs (Wang et al. 2009).”
BackgroundHippo‐yap signaling in ocular development and disease
Lee, M., Goraya, N., Kim, S., & Cho, S. (2018) · Developmental Dynamics · doi:10.1002/dvdy.24628 · Cited by 57
“After its functional significance as a major suppressor of tissue growth was first identified in Drosophila melanogaster, hippo, a downstream signal transducer (warts) and target (yorkie) were found to have great structural and functional conservation in mammals (Halder and Johnson, 2011; Hansen et al., 2015; Harvey a…”
BackgroundTAZ inhibits osteoclastogenesis by attenuating TAK1/NF-κB signaling
Yang, W., Lu, X., Zhang, T., Han, W., Li, J., He, W., Jia, Y., Zhao, K., Qin, A., & Qian, Y. (2021) · Bone Research · doi:10.1038/s41413-021-00151-3 · Cited by 58
Jang, E., Jeong, H., Kang, J. A., Kim, N., Kim, M., Choi, S., Yoo, S.-E., Hong, J., Bae, M., & Hwang, E. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01664.x · Cited by 55
“A number of transcription factors, including runt-related transcription factor 2 (RUNX2) and PPARg, have been identified as proteins that associate with TAZ in the nucleus via a Pro-Pro-X-Tyr motif (Kanai et al., 2000; Park et al., 2004; Murakami et al., 2005; Lei et al., 2008; Wang et al., 2009).”
BackgroundIwasa, H., Maimaiti, S., Kuroyanagi, H., Kawano, S., Inami, K., Timalsina, S., Ikeda, M., Nakagawa, K., & Hata, Y. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.01.020 · Cited by 57
Lin, Z., & Pu, W. T. (2014) · Stem Cell Research · doi:10.1016/j.scr.2014.04.010 · Cited by 52
“The functions of these crucial Hippo pathway components have been well addressed in several reviews on Tead (Pobbati and Hong, 2013), Yap (Wang et al., 2009), and Mst (Matallanas et al., 2008).”
FOXC2 positively regulates YAP signaling and promotes the glycolysis of nasopharyngeal carcinoma
Song, L., Tang, H., Liao, W., Luo, X., Li, Y., Chen, T., & Zhang, X. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.04.019 · Cited by 54
Tang, C., Takahashi‐Kanemitsu, A., Kikuchi, I., Ben, C., & Hatakeyama, M. (2018) · iScience · doi:10.1016/j.isci.2018.01.003 · Cited by 53
“TAZ is the one and only paralog of YAP, sharing 46% overall amino acid sequence identity with very similar structural topology (Wang et al., 2009).”
BackgroundSignaling from membrane receptors to tumor suppressor WW domain-containing oxidoreductase
Chang, J.-Y., He, R.-Y., Lin, H.-P., Hsu, L.-J., Lai, F.-J., Hong, Q., Chen, S.-J., & Chang, N.-S. (2010) · Experimental Biology and Medicine · doi:10.1258/ebm.2010.009351 · Cited by 51
Capturing the mammalian Hippo: Elucidating its role in cancer
Nishio, M., Otsubo, K., Maehama, T., Mimori, K., & Suzuki, A. (2013) · Cancer Science · doi:10.1111/cas.12227 · Cited by 55
The Hippo signal transduction network for exercise physiologists
Gabriel, B. M., Hamilton, D. L., Tremblay, A. M., & Wackerhage, H. (2016) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01076.2015 · Cited by 48
Tahmasebi, S., Ghorbani, M., Savage, P., Yan, K., Gocevski, G., Xiao, L., You, L., & Yang, X. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.465443 · Cited by 52
“a motif for interaction with WW domains such as those in two nuclear targets in hippo signaling and organ size control (37, 47, 48); ZF, zinc finger.”
BackgroundSelf-citationLats1 Deletion Causes Increased Germ Cell Apoptosis and Follicular Cysts in Mouse Ovaries1
Sun, T., Pepling, M. E., & Díaz, F. J. (2015) · Biology of Reproduction · doi:10.1095/biolreprod.114.118604 · Cited by 51
Meliambro, K. A., Wong, J., Ray, J., Calizo, R. C., Towne, S. B., Cole, B., Salem, F. E., Gordon, R. E., Kaufman, L., He, C., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.819029 · Cited by 47
“YAP functions as a transcriptional coactivator via preferential interactions with the TEAD (transcriptional enhancer–associated domain) family of transcription factors to drive expression of target genes essential for the processes of cell growth, differentiation, and survival (12, 16).”
Backgroundgga-miR-375 Plays a Key Role in Tumorigenesis Post Subgroup J Avian Leukosis Virus Infection
Li, H., Shang, H., Shu, D., Zhang, H., Ji, J., Sun, B., Li, H., & Xie, Q. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090878 · Cited by 46
“YAP1 has several domains containing a TEAD binding region and 2 WW domains, which are DNA binding domains that function as transcriptional coactivators through interactions with DNA binding transcription factors [51,52,53].”
BackgroundYAP and the drug resistance highway
Keren‐Paz, A., Emmanuel, R., & Samuels, Y. (2015) · Nature Genetics · doi:10.1038/ng.3228 · Cited by 48
Animal models and conserved processes
Greek, R., & Rice, M. J. (2012) · Theoretical Biology and Medical Modelling · doi:10.1186/1742-4682-9-40 · Cited by 47
Slattery, M. G., Voutev, R., Ma, L., Nègre, N., White, K. P., & Mann, R. S. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003753 · Cited by 46
“interact with a wide variety of transcription factors [47,88,90,91].”
BackgroundZhou, J., Liu, Y.-J., Chen, X., Zhang, X., Xu, J., Yang, K., Wang, D., Lin, S., & Ye, J. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00160 · Cited by 43
“We also found that LIPUS regulate YAP phosphorylation on serine 127 (Ser127) a key YAP1 phosphorylation site residue allows 14-3-3 binding and cytoplasmic sequestration and inactivation (Wang et al., 2009).”
BackgroundLi, Y., Wang, S., Wei, X., Zhang, S., Song, Z., Chen, X., & Zhang, J. (2018) · Cancer Science · doi:10.1111/cas.13888 · Cited by 45
The Hippo-Yes Association Protein Pathway in Liver Cancer
Lu, J., Fan, W., Dai, W., Zhou, Y., Ling, X., Shen, M., Cheng, P., & Chuanyong, G. (2013) · Gastroenterology Research and Practice · doi:10.1155/2013/187070 · Cited by 42
“In addition, TAZ has been demonstrated to interact with the P/LPXY motif at the C terminus of Glis3 to regulate Glis3-mediated gene transcription [70].”
BackgroundDedifferentiation by adenovirus E1A due to inactivation of Hippo pathway effectors YAP and TAZ
Zemke, N. R., Gou, D., & Berk, A. J. (2019) · Genes & Development · doi:10.1101/gad.324814.119 · Cited by 41
“However, the two proteins have distinctive features and probably activities (Wang et al. 2009).”
Kim, H., Son, S., Ko, Y., Lee, J. E., Kim, S., & Shin, I. (2021) · Journal of Cell Science · doi:10.1242/jcs.256503 · Cited by 40
Kim, J., Kang, D., Long, L. Z., Huang, S.-M., Yeo, M., Yi, E. S., & Kim, K. (2010) · Human Pathology · doi:10.1016/j.humpath.2010.08.003 · Cited by 40
“In contrast, loss of Hippo signaling leads to nuclear accumulation of YAP and increased YAP activity [4,6,19-22].”
BackgroundClinical implications of the Hippo-YAP pathway in multiple cancer contexts
Kim, H., & Myung, S. (2018) · BMB Reports · doi:10.5483/bmbrep.2018.51.3.018 · Cited by 39
“Drosophila genetics has been instrumental for our current knowledge about the Hippo pathway (5-8).”
BackgroundGadd, S., Beezhold, P., Jennings, L. J., George, D. W., Leuer, K., Huang, C., Huff, V., Tognon, C. E., Sorensen, P. H. B., Triche, T. J., et al. (2012) · The Journal of Pathology · doi:10.1002/path.4010 · Cited by 40
Chen, Y., Su, X., Qin, Q., Yu, Y., Jia, M., Zhang, H., Li, H., & Pei, L. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109758 · Cited by 39
WW domain-binding protein 2: an adaptor protein closely linked to the development of breast cancer
Chen, S., Wang, H., Huang, Y., Li, M., Cheng, J., Hu, P., Lu, C., Zhang, Y., Liu, N., Tzeng, C., et al. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0693-9 · Cited by 38
“Emerging studies also show that Wnt signaling promotes breast cancer by blocking ITCH-mediated (an ubiquitin-conjugating enzyme) ubiquitin-dependent degradation of the YAP/TAZ transcriptional coactivator WBP2, suggesting WBP2/ITCH signaling functions to bridge the complex Wnt and Hippo signaling networks in breast can…”
BackgroundInfluentialMaruyama, J., Inami, K., Michishita, F., Jiang, X., Iwasa, H., Nakagawa, K., Ishigami‐Yuasa, M., Kagechika, H., Miyamura, N., Hirayama, J., et al. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0382 · Cited by 37
“The effects on the phosphorylation of YAP1 YAP1 is negatively regulated by the canonical Hippo pathway via the phosphorylation (8).”
BackgroundRoles of H ippo signaling pathway in size control of organ regeneration
Hayashi, S., Yokoyama, H., & Tamura, K. (2015) · Development Growth & Differentiation · doi:10.1111/dgd.12212 · Cited by 36
“Taz (Wwtr1) is a paralogue of Yap, and it is also thought to be regulated and function in a manner similar to that of Yap (Wang et al. 2009).”
BackgroundThe Evaluation of WBP2NL-Related Genes Expression in Breast Cancer
Nourashrafeddin, S., Aarabi, M., Modarressi, M. H., Rahmati, M., & Nouri, M. (2014) · Pathology & Oncology Research · doi:10.1007/s12253-014-9820-8 · Cited by 36
Yang, R., Wu, Y., Zou, J., Zhou, J., Wang, M., Hao, X., & Cui, H. (2016) · Oncotarget · doi:10.18632/oncotarget.9199 · Cited by 35
Li, J., Fang, L., Yu, W., & Wang, Y. (2015) · Oncology Letters · doi:10.3892/ol.2015.2973 · Cited by 34
Zhang, Q., Fang, X. H., Zhao, W., & Liang, Q. (2018) · Gene · doi:10.1016/j.gene.2018.11.068 · Cited by 35
The Hippo–YAP Signaling as Guardian in the Pool of Intestinal Stem Cells
Seo, Y., Park, S., Kim, H., & Nam, J. (2020) · Biomedicines · doi:10.3390/biomedicines8120560 · Cited by 35
Metadata
- Authors
- Wang, K., Degerny, C., Xu, M., & Yang, X.-J.
- Affiliations
- McGill University Health Centre (CA)
- Corresponding author
- Yang, Xiang-Jiao
- Venue
- Biochemistry and Cell Biology
- Publisher
- Canadian Science Publishing
- Published
- 2009-02
- Volume
- 87
- Issue
- 1
- Pages
- 77-91
- ISSN
- 0829-8211 (ISSN-L)
- 1208-6002
- OpenAlex
- W2119035325
- Cited by
- 180
- References
- 114
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 5 · 2023: 3 · 2022: 9 · 2021: 10 · 2020: 8 · 2019: 9 · 2018: 12 · 2017: 12 · 2016: 10 · 2015: 16 · 2014: 13 · 2013: 19 · 2012: 13
- FWCI
- 1.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.nrcresearchpress.com/page/about/CorporateTextAndDataMining (tdm)
- Locations
- Biochemistry and Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- McGill University
- Canadian Institutes of Health Research
- Solar Energy Technologies Office
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hippo pathway signaling and YAP/TAZ
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- YAP, TAZ, Yorkie, transcriptional coregulators, 14-3-3 binding, nuclear import, TEAD transcription factors, Runx transcription factors, PPARγ, TBX5, signal transduction, animal development, carcinogenesis, sequence conservation
- MeSH terms
- Amino Acid Sequence, Animals, Disease, Humans, Molecular Sequence Data, Protein Binding, Transcription Factors, Signal Transduction, Conserved Sequence, Embryonic Development
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.